Both in Pharmaceuticals
Equillium vs Anixa Biosciences
Over the past year EQ returned −2.8% and ANIX returned −17.4%; their daily moves had a correlation of 0.15.
EQ −2.8% ANIX −17.4%Growth of $1, one year, split-adjusted
| Metric | EQ | ANIX |
|---|---|---|
| Price | $1.40 | $3.28 |
| Market cap | $109.7M | $114.0M |
| Today | −0.71% | +7.37% |
| 1 month | −1.4% | +8.6% |
| 6 months | −35.5% | +7.2% |
| Year to date | −9.7% | +5.1% |
| 1 year | −9.7% | −20.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $57.2M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 89.6% | 60.6% |
| Short % of float | 12.6% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).